Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
Abstract Introduction Concurrent chemoradiation is the standard of care in inoperable locally advanced squamous cell head and neck cancers. The most widely accepted schedule of concomitant cisplatin is 100mg/m2 given on a 3 weekly basis but the optimal regime is unknown. Ob...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Thieme Revinter Publicações Ltda.
2017-04-01
|
| Seri Bilgileri: | International Archives of Otorhinolaryngology |
| Konular: | |
| Online Erişim: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0036-1594020 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|